WHO Global Influenza Surveillance and Response System working group on surveillance of influenza antiviral susceptibility.
D000998:Antiviral Agents / Q000494:pharmacology*; D024882:Drug Resistance, Viral / Q000235:genetics; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D014943:Global Health; D006801:Humans; D057921:Influenza A Virus, H10N7 Subtype / Q000145:classification / Q000187:drug effects* / Q000235:genetics; D007251:Influenza, Human / Q000188:drug therapy* / Q000453:epidemiology / Q000821:virology; D008826:Microbial Sensitivity Tests / Q000379:methods / Q000592:standards; D009439:Neuraminidase / Q000037:antagonists & inhibitors* / Q000235:genetics; D053139:Oseltamivir / Q000494:pharmacology; D020641:Polymorphism, Single Nucleotide; D011159:Population Surveillance; D017410:Practice Guidelines as Topic; D014944:World Health Organization; D053243:Zanamivir / Q000494:pharmacology
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase; D053243:Zanamivir